BI 14332 CL
Sponsors
Boehringer Ingelheim
Conditions
Diabetes Mellitus, Type 2Healthy
Phase 1
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 14332 CL Powder in Healthy Male Subjects
CompletedNCT02211989
Start: 2006-02-28Updated: 2014-08-08
Influence of a Standardised High Fat Breakfast on the Bioavailability of BI 14332 CL in Healthy Male Volunteers
CompletedNCT02212938
Start: 2006-09-30Updated: 2014-08-08
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 14332 CL as Tablet in Female and Male Patients With Type 2 Diabetes
TerminatedNCT02212925
Start: 2006-11-30Updated: 2014-08-08